Krsnaa Diagnostics Limited (KRSNAA.BO)
Krsnaa Diagnostics Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Pune, MH, IN. The stock last traded at $576.10, up 4.50% on the session, giving a market capitalisation of $18.72B. Its beta of 0.06 implies it has historically moved less than the broad market.
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, such as ophthalmic test, mammography, dental imaging, stress test, dual-energy X-ray absorptiometry scan, and bone mineral density test. It serves individual patients, government clients, corporate clients, hospitals, clinics, private practitioner, and other healthcare providers. Krsnaa Diagnostics Limited was incorporated in 2010 and is based in Pune, India.
Krsnaa Diagnostics Limited is most often compared with the following Healthcare names: